XKRX
XK-related protein 2
Also known as: XKR2, XKR2_HUMAN, XPLAC
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PP77
- Gene
- XKRX
- Ensembl
- ENSG00000182489
- Chromosome
- X
- Canonical length
- 449 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a protein that is related to a component of the XK/Kell complex of the Kell blood group system. The encoded protein includes several transmembrane domains, is known to be exposed to the cell surface, and may function as a membrane transporter. [provided by RefSeq, May 2010]
Canonical amino-acid sequenceUniProt
449 residues, UniProt reviewed canonical sequence.
>Q6PP77|XKRX
1 MDRVYEIPEE PNVDPVSSLE EDVIRGANPR FTFPFSILFS TFLYCGEAAS ALYMVRIYRK
61 NSETYWMTYT FSFFMFSSIM VQLTLIFVHR DLAKDKPLSL FMHLILLGPV IRCLEAMIKY
121 LTLWKKEEQE EPYVSLTRKK MLIDGEEVLI EWEVGHSIRT LAMHRNAYKR MSQIQAFLGS
181 VPQLTYQLYV SLISAEVPLG RVVLMVFSLV SVTYGATLCN MLAIQIKYDD YKIRLGPLEV
241 LCITIWRTLE ITSRLLILVL FSATLKLKAV PFLVLNFLII LFEPWIKFWR SGAQMPNNIE
301 KNFSRVGTLV VLISVTILYA GINFSCWSAL QLRLADRDLV DKGQNWGHMG LHYSVRLVEN
361 VIMVLVFKFF GVKVLLNYCH SLIALQLIIA YLISIGFMLL FFQYLHPLRS LFTHNVVDYL
421 HCVCCHQHPR TRVENSEPPF ETEARQSVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against XKRX can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 9.3 nTPM
Expression across tissuesHPA
Tissue
- skin: 9.3 nTPM
- tonsil: 3.2 nTPM
- small intestine: 2.3 nTPM
- esophagus: 2.2 nTPM
- thymus: 1.7 nTPM
- vagina: 1.6 nTPM
Single-cell type
- adrenal medulla cells: 21 nCPM
- respiratory deuterosomal cells: 18 nCPM
- pituicytes/fscs: 17 nCPM
- transitional alveolar cells: 14 nCPM
- esophageal apical cells: 13 nCPM
- alveolar cells type 1: 10 nCPM
Immune cell
- naive B-cell: 1.9 nTPM
- naive CD4 T-cell: 1.5 nTPM
- naive CD8 T-cell: 1.2 nTPM
- MAIT T-cell: 0.2 nTPM
- memory B-cell: 0.2 nTPM
- total PBMC: 0.2 nTPM
Brain region
- hypothalamus: 4 nTPM
- amygdala: 1.3 nTPM
- midbrain: 1.2 nTPM
- pons: 1 nTPM
- basal ganglia: 0.9 nTPM
- cerebral cortex: 0.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads XKRX as an antibody target. Whether an autoantibody or antibody against XKRX could matter depends on whether native XKRX is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
XKRX is annotated at the cell surface, where native XKRX is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label XKRX as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...